一项关于多发性骨髓瘤自体骨髓移植联合干细胞基因标记的I期研究。 - Suppr

Suppr

超能文献

A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma.

作者信息

Stewart A K, Dubé I D, Kamel-Reid S, Keating A

机构信息

Department of Medicine, Toronto Hospital, Ontario, Canada.

出版信息

Hum Gene Ther. 1995 Jan;6(1):107-19. doi: 10.1089/hum.1995.6.1-107.

DOI:10.1089/hum.1995.6.1-107

PMID:7703282

Abstract

摘要

相似文献

A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma.一项关于多发性骨髓瘤自体骨髓移植联合干细胞基因标记的I期研究。

Hum Gene Ther. 1995 Jan;6(1):107-19. doi: 10.1089/hum.1995.6.1-107.

Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.临床研究项目的修订。使用逆转录病毒载体进行基因标记，以研究在多发性骨髓瘤、慢性粒细胞白血病或转移性乳腺癌患者自体移植后干细胞基因转移的可行性及造血重建生物学特性。

Hum Gene Ther. 1993 Apr;4(2):205-22. doi: 10.1089/hum.1993.4.2-205.

Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma.

Hum Gene Ther. 1994 Oct;5(10):1279-86. doi: 10.1089/hum.1994.5.10-1279.

Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.自体长期骨髓培养物移植后基因标记造血祖细胞在骨髓瘤患者中的植入。

Hum Gene Ther. 1999 Aug 10;10(12):1953-64. doi: 10.1089/10430349950017310.

Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.高剂量ICE（异环磷酰胺、卡铂、依托泊苷）化疗联合经neoR转导的骨髓和外周血干细胞进行自体骨髓移植（ABMT）治疗转移性乳腺癌患者的初步研究。

Hum Gene Ther. 1993 Jun;4(3):331-54. doi: 10.1089/hum.1993.4.3-331.

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.多发性骨髓瘤自体干细胞移植后基因标记的CD34+细胞的长期随访

Cancer Gene Ther. 2007 Mar;14(3):227-32. doi: 10.1038/sj.cgt.7701006. Epub 2006 Nov 3.

Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation.在接受自体骨髓移植的患者中，使用逆转录病毒载体进行双重标记以确定未处理及细胞因子扩增的CD34+选择骨髓细胞的重建率。

Hum Gene Ther. 1996 Mar 20;7(5):655-67. doi: 10.1089/hum.1996.7.5-655.

Advances in the treatment of multiple myeloma.多发性骨髓瘤的治疗进展

Adv Intern Med. 1998;43:279-320.

Autologous and allogeneic transplants for multiple myeloma.

Semin Hematol. 1995 Jan;32(1):31-44.

Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.

Bone Marrow Transplant. 1991;7 Suppl 2:30.

引用本文的文献

Gene-marking studies of hematopoietic cells.造血细胞的基因标记研究。

Int J Hematol. 2001 Jan;73(1):14-22. doi: 10.1007/BF02981898.

Multiple myeloma: VI International Workshop, June 14-18, 1997, Boston, Massachusetts, USA.多发性骨髓瘤：第六届国际研讨会，1997年6月14日至18日，美国马萨诸塞州波士顿

Med Oncol. 1998 Apr;15(1):1-5. doi: 10.1007/BF02787337.

Multiple myeloma, high-dose treatment and autologous stem cell transplantation--current status.多发性骨髓瘤、大剂量治疗及自体干细胞移植——现状

Med Oncol. 1996 Mar;13(1):23-30. doi: 10.1007/BF02988838.

Gene therapy: here to stay.基因疗法：将持续存在。

CMAJ. 1995 May 15;152(10):1605-13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验